Notice of a Pre-Application Webinar for RFA-CA-19-007 and RFA-CA-19-008 on the Experimental Therapeutics Clinical Trials Network (ETCTN) (UM1) and ETCTN Pharmacokinetic Resource Laboratories (U24), respectively

Notice Number: NOT-CA-19-021

Key Dates
Release Date: January 17, 2019

Related Announcements


Issued by
National Cancer Institute (NCI)


The National Cancer Institute (NCI) will hold a pre-application webinar on Wednesday, February 6, 2019 from 1:00-3:00 PM (EDT) for two closely related Funding Opportunity Announcements (FOAs):

1) RFA-CA-19-007 Experimental Therapeutics Clinical Trials Network (ETCTN) (UM1 Clinical Trial Required); and
2) RFA-CA-19-008 ETCTN Pharmacokinetic Resource Laboratories (U24 Clinical Trial Not Allowed).

NCI staff members involved in these FOAs will provide orientation and technical assistance to potential applicants by explaining the goals and objectives for both FOAs and answering questions from attendees. Potential applicants are encouraged to submit their questions by January 25, 2018 by email to .

To participate in the webinar, registration is required through WebEx. See ETCTN webinar info for details on webinar registration and access.

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-19-007 or to RFA-CA-19-008.


For all inquiries related to this webinar, contact:
S. Percy Ivy, MD
National Cancer Institute (NCI)
Telephone: 240-276-6565
Email: to